New pill shows promise for Hard-to-Treat blood cancers
Disease control
Terminated
This study tests an oral medication called emavusertib (CA-4948) in adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) that has returned or not responded to prior treatments. The goal is to find the safest and most effective dose and to see if th…
Phase: PHASE1, PHASE2 • Sponsor: Curis, Inc. • Aim: Disease control
Last updated May 17, 2026 07:49 UTC